Deerfield Beach, FL -- (SBWIRE) -- 07/01/2016 -- Acne vulgar is a long lasting skin disease that occurs when dead skin cells and oil from the skin become clogged with hair follicles or skin pores. Acne vulgar market affects to the areas of skin includes the face, the upper part of the chest, and the back. Severe acne is inflammatory, but acne can also manifest in noninflammatory forms. Acne lesions are commonly known as spot, pimples and blemishes.

The major driving factor for the global acne vulgaris treatment market is rapidly growing population of the world and increasing number of teenagers suffering from skin disease. Acne is the most common skin disorder in the U.S. hence, it expected to drive the growth in North America region. The study includes drivers and restraints for the acne vulgaris treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the acne vulgaris treatment market on a global level.

Read More @ http://www.syndicatemarketresearch.com/market-analysis/acne-vulgaris-treatment-market.html

The report covers forecast and analysis for the acne vulgaris treatment market on a global and regional level. The report also offers detailed competitive landscape of the global acne vulgaris treatment market. The report provides detailed segmentation of the acne vulgaris treatment market based on treatment segment and region.

The Treatment segment segmented into therapeutics and other treatment. Therapeutics segment is further bifurcated into as antibiotics (erythromycin and clindamycin), retinoid (adapalene, tazaroteen, tretinoin and isotretinoin), combination medications, anti-inflammatory, hormonal agents and other agents (azelaic acid and resorcinol). Other treatment includes laser and light therapy, cosmetic procedures and acne scar treatments. Therapeutics accounted for largest segment for acne vulgaris treatment market and expected to be significant growth over the forecast period.

The report aims to provide a comprehensive overview of market data and trends in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation of region on the country level, which includes U.S., Germany, UK, France, China, Japan and India. Among the all region, North America was dominated the acne vulgaris treatment market and expected to exhibit strong growth over the forecast period. Europe accounted for significant share for acne vulgaris treatment market.

Some of the key players in the acne vulgaris treatment market includes Galderma S.A., Hygeia Laboratories Inc., Allergan, Stiefel Laboratories, Inc. Bayer AG, Cipher, Johnson & Johnson Private Limited and Valeant Pharmaceutical International Inc.

Access sample report visit at http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=50879

Acne Vulgaris Treatment Market: Treatment Segment Analysis

Therapeutics

Retinoid (Adapalene, Tazaroteen, Tretinoin and Isotretinoin)
Antibiotics (Erythromycin and Clindamycin)
Hormonal agents, combination medications, anti-inflammatory
other agents (Azelaic acid and Resorcinol)

Others (laser & light therapy, cosmetic procedures acne scar treatments)
Acne Vulgaris Treatment Market: Regional Segment Analysis

North America

U.S.

Europe

UK
France
Germany

Asia Pacific

China
Japan
India

Latin America

Brazil

Middle East & Africa
Read More @ http://www.syndicatemarketresearch.com/market-analysis/acne-vulgaris-treatment-market.html

Contact US:

Joel John
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Email: sales@syndicatemarketresearch.com
Website: http://www.syndicatemarketresearch.com/